Lophius Biosciences

Lophius Biosciences is a biotech company focusing on research, development and marketing in the field of infectious and autoimmune diseases.

We aim to make personalized therapies possible by using innovative diagnostic products which monitor pathogen-specific immune responses. The core competences of Lophius Biosciences are in the areas of infectious diseases as well as transplantation and T-cell immunology.

24.10.2011

Lophius Biosciences presents T-Track© CMV/EBV tests at congress after conclusion of product development and initiation of a clinical validation study

read more

18.07.2011

Lophius Biosciences closes additional financing round with current investors totaling 1.4 million EUR

read more

11.07.2011

Lophius Biosciences Expands its Management Team and Prepares for Market Entry at the Beginning of 2012

read more more news